David E Moller

3PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 15, 2021
Imeglimin preserves islet β-cell mass in Type 2 diabetic ZDF rats.

Sophie Hallakou-Bozec, Micheline Kergoat, David E Moller

|Feb 19, 2021
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.

Sophie Hallakou-Bozec, Micheline Kergoat, Pascale Fouqueray

|Dec 03, 2020
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.

Sophie Hallakou-Bozec, Guillaume Vial, Micheline Kergoat

Pageof 1